What Can Proteomics Tell Us about Tuberculosis? |
Susana Flores-Villalva
(INIFAP, Centro Nacional de Investigacion Disciplinaria en Fisiologia y Mejoramiento Animal)
Elba Rogriguez-Hernandez (INIFAP, Centro Nacional de Investigacion Disciplinaria en Fisiologia y Mejoramiento Animal) Yesenia Rubio-Venegas (Facultad de Ciencias Naturales, Universidad Autonoma de Queretaro) Jorge Germinal Canto-Alarcon (Facultad de Ciencias Naturales, Universidad Autonoma de Queretaro) Feliciano Milian-Suazo (Facultad de Ciencias Naturales, Universidad Autonoma de Queretaro) |
1 | Xiong Y, Chalmers MJ, Gao FP, Cross TA, Marshall AG. 2005. Identification of Mycobacterium tuberculosis H37Rv integral membrane proteins by one-dimensional gel electrophoresis and liquid chromatography electrospray ionization tandem mass spectrometry. J. Proteome Res. 4: 855-861. DOI |
2 | Yang H, Troudt J, Grover A, Arnett K, Lucas M, Cho YS, et al. 2011. Three protein cocktails mediate delayed-type hypersensitivity responses indistinguishable from that elicited by purified protein derivative in the guinea pig model of Mycobacterium tuberculosis infection. Infect. Immun. 79: 716-723. DOI |
3 | Xolalpa W, Vallecillo AJ, Lara M, Mendoza-Hernandez G, Comini M, Spallek R, Singh M, Espitia C. 2007. Identification of novel bacterial plasminogen-binding proteins in the human pathogen Mycobacterium tuberculosis. Proteomics 7: 3332-3341. DOI |
4 | Yang H, Kruh-Garcia NA, Dobos KM. 2012. Purified protein derivatives of tuberculin - past, present, and future. FEMS Immunol. Med Microbiol. 66: 273-280. DOI |
5 | Young DB, Kaufmann SHE, Hermans PWM. 1992. Mycobacterial protein antigens: a compilation. Mol. Microbiol. 6: 133-145. DOI |
6 | Zheng J, Liu L, Wei C, Leng W, Yang J, Li W, et al. 2012. A comprehensive proteomic analysis of Mycobacterium bovis bacillus Calmette-Guérin using high resolution Fourier transform mass spectrometry. J. Proteomics 77: 357-371. DOI |
7 | Zheng J, Ren X, Wei C, Yang J, Hu Y, Liu L, Xu X, Wang J, Jin Q. 2013. Analysis of the secretome and identification of novel constituents from culture filtrate of bacillus Calmette-Guerin using high-resolution mass spectrometry. Mol. Cell. Proteomics 12: 2081-2095. DOI |
8 | Starck J, Källenius G, Marklund B-I, Andersson DI, Akerlund T. 2004a. Comparative proteome analysis of Mycobacterium tuberculosis grown under aerobic and anaerobic conditions. Microbiology 150: 3821-3829. DOI |
9 | Weldingh K, Rosenkrands I, Jacobsen S, Birk P, Elhay MJ, Andersen P, et al. 1998. Two-dimensional electrophoresis for analysis of Mycobacterium tuberculosis culture filtrate and purification and characterization of six novel proteins. Infect. Immun. 66: 3492-3500. |
10 | Vilchèze C, Molle V, Carrère-Kremer S, Leiba J, Mourey L, Shenai S, et al. 2014. Phosphorylation of KasB regulates virulence and acid-fastness in Mycobacterium tuberculosis. PLoS Pathog. 10: e1004115. DOI |
11 | Vordermeier M, Jones GJ, Whelan AO. 2011. DIVA reagents for bovine tuberculosis vaccines in cattle. Expert Rev. Vaccines 10: 1083-1091. DOI |
12 | Wang Z, Potter BM, Gray AM, Sacksteder KA, Geisbrecht BV, Laity JH. 2007. The solution structure of antigen MPT64 from Mycobacterium tuberculosis defines a new family of beta-grasp proteins. J. Mol. Biol. 366: 375-381. DOI |
13 | Wiker HG. 2009. MPB70 and MPB83--major antigens of Mycobacterium bovis. Scand. J. Immunol. 69: 492-499. DOI |
14 | Sidders B, Pirson C, Hogarth PJ, Hewinson RG, Stoker NG, Vordermeier HM, Ewer K. 2008. Screening of highly expressed mycobacterial genes identifies Rv3615c as a useful differential diagnostic antigen for the Mycobacterium tuberculosis complex. Infect. Immun. 76: 3932-3939. DOI |
15 | Wilson RA, Maughan WN, Kremer L, Besra GS, Fütterer K. 2004. The structure of Mycobacterium tuberculosis MPT51 (FbpC1) defines a new family of non-catalytic alpha/beta hydrolases. J. Mol. Biol. 335: 519-530. DOI |
16 | World Health Organization. 2013. Global Tuberculosis Report. France, WHO. |
17 | Wu L, Zhang M, Sun M, Jia B, Wang X. 2011. Humoural immune responses to a recombinant 16-kDa-38-kDa--ESAT-6 Mycobacterial Antigen in tuberculosis. J. Int. Med. Res. 39: 514-521. DOI |
18 | Smith CV, Huang C, Miczak A, Russell DG, Sacchettini JC, Höner zu Bentrup K. 2003. Biochemical and structural studies of malate synthase from Mycobacterium tuberculosis. J. Biol. Chem. 278: 1735-1743. DOI |
19 | Siddiqui KF, Amir M, Agrewala JN. 2011. Understanding the biology of 16 kDa antigen of Mycobacterium tuberculosis: scope in diagnosis, vaccine design and therapy. Crit. Rev. Microbiol. 37: 349-357. DOI |
20 | Singhal N, Sharma P, Kumar M, Joshi B, Bisht D. 2012. Analysis of intracellular expressed proteins of Mycobacterium tuberculosis clinical isolates. Proteome Sci. 10: 14. DOI |
21 | Sinha S, Kosalai K, Arora S, Namane A, Sharma P, Gaikwad AN, et al. 2005. Immunogenic membraneassociated proteins of Mycobacterium tuberculosis revealed by proteomics. Microbiology 151: 2411-2419. DOI |
22 | Rosenkrands I, King A, Weldingh K, Moniatte M, Moertz E, Andersen P. 2000. Towards the proteome of Mycobacterium tuberculosis. Electrophoresis 21: 3740-3756. DOI |
23 | Sonnenberg MG, Belisle JT. 1997. Definition of Mycobacterium tuberculosis culture filtrate proteins by two-dimensional polyacrylamide gel electrophoresis, N-terminal amino acid sequencing, and electrospray mass spectrometry. Infect. Immun. 65: 4515-4524. |
24 | Sørensen AL, Nagai S, Houen G, Andersen P, Andersen AB. 1995. Purification and characterization of a low-molecularmass T-cell antigen secreted by Mycobacterium tuberculosis. Infect. Immun. 63: 1710-1717. |
25 | Sreejit G, Ahmed A, Parveen N, Jha V, Valluri VL, Ghosh S, Mukhopadhyay S. 2014. The ESAT-6 protein of Mycobacterium tuberculosis interacts with beta-2-microglobulin (β2M) affecting antigen presentation function of macrophage. PLoS Pathog. 10: e1004446. DOI |
26 | Russell RB, Eggleston DS. 2000. New roles for structure in biology and drug discovery. Nat. Struct. Biol. 7: 928-930. DOI |
27 | Rosenkrands I, Slayden RA, Crawford J, Aagaard C, Barry CE III, Andersen P. 2002. Hypoxic response of Mycobacterium tuberculosis studied by metabolic labeling and proteome analysis of cellular and extracellular proteins. J. Bacteriol. 184: 3485-3491. DOI |
28 | Rosenkrands I, Weildingh K, Jacobsen S, Hansen VC, Florio W, Gianetri I, Andersen P. 2000. Mapping and identification of Mycobacterium tuberculosis proteins by two-dimensional gel electrophoresis, microsequencing and immunodetection. Electrophoresis 21: 935-948. DOI |
29 | Russell DG. 2007. Who puts the tubercle in tuberculosis? Nat. Rev. Microbiol. 5: 39-47. DOI |
30 | Ryndak M, Wang S, Smith I. 2008. PhoP, a key player in Mycobacterium tuberculosis virulence. Trends Microbiol. 16: 528-534. DOI |
31 | Sachdeva P, Misra R, Tyagi AK, Singh Y. 2010. The sigma factors of Mycobacterium tuberculosis: regulation of the regulators. FEBS J. 277: 605-626. DOI |
32 | Sajid A, Arora G, Gupta M, Singhal A, Chakraborty K, Nandicoori VK, Singh Y. 2011. Interaction of Mycobacterium tuberculosis elongation factor Tu with GTP is regulated by phosphorylation. J. Bacteriol. 193: 5347-5358. DOI |
33 | Shukla S, Richardson ET, Athman JJ, Shi L, Wearsch PA, McDonald D, et al. 2014. Mycobacterium tuberculosis lipoprotein LprG binds lipoarabinomannan and determines its cell envelope localization to control phagolysosomal fusion. PLoS Pathog. 10: e1004471. DOI |
34 | Pethe K, Alonso S, Biet F, Delogu G, Brennan MJ, Locht C, Menozzi FD. 2001. The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination. Nature 412: 190-194. DOI |
35 | Raynaud, Papavinasasundaram KG, Speight RA, Springer B, Sander P, Böttger EC, et al. 2002. The functions of OmpATb, a pore-forming protein of Mycobacterium tuberculosis. Mol. Microbiol. 46: 191-201. DOI |
36 | Pieters J. 2008. Mycobacterium tuberculosis and the macrophage: maintaining a balance. Cell Host Microbe. 3: 399-407. DOI |
37 | Prasad TSK, Verma R, Kumar S, Nirujogi RS, Sathe GJ, Madugundu AK, et al. 2013. Proteomic analysis of purified protein derivative of Mycobacterium tuberculosis. Clin. Proteomics 10: 8. DOI |
38 | Puffer RR, Steward HC, Gass. RS. 1945. Tuberculosis in house- hold contacts associates: the inuence of age and relationship. Am. Rev. Tuberc 52: 89-103. |
39 | Rifat D, Belchis DA, Karakousis PC. 2014. senX3- independent contribution of regX3 to Mycobacterium tuberculosis virulence. BMC Microbiol. 14: 265. DOI |
40 | Reddy MCM, Kuppan G, Shetty ND, Owen JL, Ioerger TR, Sacchettini JC. 2008. Crystal structures of Mycobacterium tuberculosis S-adenosyl-L-homocysteine hydrolase in ternary complex with substrate and inhibitors. Protein Sci. 17: 2134-2144. DOI |
41 | Roberts MM, Coker AR, Fossati G, Coates ARM, Wood SP, Mascagni P. 2003. Mycobacterium tuberculosis chaperonin 10 heptamers self-associate through their biologically active loops. J. Bacteriol. 185: 4172-4185. DOI |
42 | Rohde K, Yates RM, Purdy GE, Russell DG. 2007. Mycobacterium tuberculosis and the environment within the phagosome. 219: 37-54. DOI |
43 | Nagai S, Wiker HG, Harboe M, Kinomoto M. 1991. Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis. Infect. Immun. 59: 372-382. |
44 | Patel VJ, Thalassinos K, Slade SE, Connolly JB, Crombie A, Murrell JC, Scrivens JH. 2009. A comparison of labeling and label-free mass spectrometry-based proteomics approaches. J. Proteome Res. 8: 3752-3759. DOI |
45 | O’Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, Berry MPR. 2013. The immune response in tuberculosis. Annu. Rev. Immunol. 31: 475-527. DOI |
46 | Pai RK, Convery M, Hamilton TA, Boom WH, Harding CV. 2003. Inhibition of IFN- -induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion. J. Immunol. 171: 175-184. DOI |
47 | Parish T. 2003. The senX3-regX3 two-component regulatory system of Mycobacterium tuberculosis is required for virulence. Microbiology 149: 1423-1435. DOI |
48 | Monahan IM, Betts J, Banerjee DK, Butcher PD. 2001. Differential expression of mycobacterial proteins following phagocytosis by macrophages. Microbiology 147: 459-471. DOI |
49 | Pecora ND, Gehring AJ, Canaday DH, Boom WH, Harding CV. 2006. Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC function. J. Immunol. 177: 422-429. DOI |
50 | Mawuenyega KG, Forst CV, Dobos KM, Belisle JT, Chen J, Bradbury EM, et al. 2005. Mycobacterium tuberculosis functional network analysis by global subcellular protein profiling. Mol. Biol. Cell 16: 396-404. DOI |
51 | Målen H, Berven FS, Søfteland T, Arntzen MØ, D’Santos CS, De Souza GA, Wiker HG. 2008. Membrane and membrane-associated proteins in Triton X-114 extracts of Mycobacterium bovis BCG identified using a combination of gel-based and gel-free fractionation strategies. Proteomics 8: 1859-1870. DOI |
52 | Mattow J, Jungblut PR, Schaible UE, Mollenkopf H, Lamer S, Zimny-arndt U, et al. 2001. Identification of proteins from Mycobacterium tuberculosis missing in attenuated Mycobacterium bovis BCG strains. Electrophoresis 22: 2936-2946. DOI |
53 | Målen H, Pathak S, Søfteland T, de Souza GA, Wiker HG. 2010. Definition of novel cell envelope associated proteins in Triton X-114 extracts of Mycobacterium tuberculosis H37Rv. BMC Microbiol. 10: 132. DOI |
54 | Målen H, De Souza G a, Pathak S, Søfteland T, Wiker HG. 2011. Comparison of membrane proteins of Mycobacterium tuberculosis H37Rv and H37Ra strains. BMC Microbiol. 11: 18. DOI |
55 | Manca C, Lyashchenko K, Colangeli R, Gennaro ML, Manca C, Lyashchenko K, et al. 1997. MTC28, a novel 28-kilodalton proline-rich secreted antigen specific for the Mycobacterium tuberculosis complex. Infect. Immun. 65: 4951-4957. |
56 | Jungblut PR, Schaible UE, Mollenkopf HJ, Zimny-Arndt U, Raupach B, Mattow J, et al. 1999. Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains: towards functional genomics of microbial pathogens. Mol. Microbiol. 33: 1103-1117. DOI |
57 | Mattow J, Schaible UE, Schmidt F, Hagens K, Siejak F, Brestrich G, et al. 2003. Comparative proteome analysis of culture supernatant proteins from virulent Mycobacterium tuberculosis H37Rv and attenuated M. bovis BCG Copenhagen. Electrophoresis 24: 3405-3420. DOI |
58 | Mattow J, Siejak F, Hagens K, Becher D, Albrecht D, Krah A, et al. 2006. Proteins unique to intraphagosomally grown Mycobacterium tuberculosis. Proteomics 6: 2485-2494. DOI |
59 | Jungblut PR, Müller E, Mattow J, Kaufmann SHE. 2001. Proteomics reveals open reading frames in Mycobacterium tuberculosis H37Rv not predicted by genomics. Infect. Immun. 69: 5905-5907. DOI |
60 | Kurtz S, McKinnon KP, Runge MS, Ting JP-Y, Braunstein M. 2006. The SecA2 secretion factor of Mycobacterium tuberculosis promotes growth in macrophages and inhibits the host immune response. Infect. Immun. 74: 6855-6864. DOI |
61 | Kremer L, Maughan WN, Wilson RA, Dover LG, Besra GS. 2002. The M. tuberculosis antigen 85 complex and mycolyltransferase activity. Lett. Appl. Microbiol. 34: 233-237. DOI |
62 | Kruh NA, Troudt J, Izzo A, Prenni J, Dobos KM. 2010. Portrait of a pathogen: the Mycobacterium tuberculosis proteome in vivo. PLoS One 5: e13938. DOI |
63 | Kulchavenya E. 2014. Extrapulmonary tuberculosis: are statistical reports accurate? Ther. Adv. Infect. Dis. 2: 61-70. DOI |
64 | Lee B, Horwitz MA. 1995. Identification of Macrophage and Stress-induced Proteins of Mycobacterium tuberculosis. J. Clin. Invest. 96: 245-249. DOI |
65 | Goulding CW, Parseghian A, Sawaya MR, Cascio D, Apostol MI, Gennaro ML, Eisenberg D. 2002. Crystal structure of a major secreted protein of Mycobacterium tuberculosis-MPT63 at 1.5-A resolution. Protein Sci. 11: 2887-2893. DOI |
66 | Lew JM, Kapopoulou A, Jones LM, Cole ST. 2011. TubercuList--10 years after. Tuberculosis 91: 1-7. DOI |
67 | Målen H, Berven FS, Fladmark KE, Wiker HG. 2007. Comprehensive analysis of exported proteins from Mycobacterium tuberculosis H37Rv. Proteomics 7: 1702-1718. DOI |
68 | González-Zamorano M, Mendoza-Hernández G, Xolalpa W, Parada C, Vallecillo AJ, Bigi F, Espitia C. 2009. Mycobacterium tuberculosis glycoproteomics based on ConAlectin affinity capture of mannosylated proteins. J. Proteome Res. 8: 721-733. DOI |
69 | Jagusztyn-krynicka ELBK, Roszczenko P, Grabowska A. 2009. Impact of proteomics on anti-Mycobacterium tuberculosis (MTB) vaccine development. Polish J. Microbiol. 58: 281-287. |
70 | Gu S, Chen J, Dobos KM, Bradbury EM, Belisle JT, Chen X. 2003. Comprehensive proteomic profiling of the membrane constituents of a Mycobacterium tuberculosis strain. Mol. Cell. Proteomics 2: 1284-1296. DOI |
71 | Gunawardena HP, Feltcher ME, Wrobel JA, Gu S, Miriam B, Chen X. 2013. Comparison of the membrane proteome of virulent Mycobacterium tuberculosis and the attenuated Mycobacterium bovis BCG vaccine strain by label-free quantitative proteomics. J. Proteome Res. 12: 5463-5474. DOI |
72 | Jagirdar J, Zagzag D. 1996. Pathology and insights into pathogenesis of tuberculosis, pp. 467-482. In Rom WN, Garay SM (eds.). Tuberculosis. 1st Ed. Little, Brown and Company, New York, N.Y. |
73 | Forrellad MA, Klepp LI, Gioffré A, Sabio y García J, Morbidoni HR, et al. 2013. Virulence factors of the Mycobacterium tuberculosis complex. Virulence 4: 3-66. DOI |
74 | Jiang XIN, Zhang W, Gao F, Huang Y, Lv C, Wang H. 2006. Comparison of the proteome of isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis. Microb. Drug Resist. 12: 231-238. DOI |
75 | Johnson S, Brusasca P, Spencer JS, Wiker HG, Shashkina E, Kreiswirth B, et al. 2001. Characterization of the secreted MPT53 antigen of Mycobacterium tuberculosis. Infect. Immun. 69: 5936-5939. DOI |
76 | Flynn JL, Chan J. 2003. Immune evasion by Mycobacterium tuberculosis: living with the enemy. Curr. Opin. Immunol. 15: 450-455. DOI |
77 | Gehring AJ, Dobos KM, Belisle JT, Harding CV, Boom WH. 2004. Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing. J. Immunol. 173: 2660-2668. DOI |
78 | Forrellad MA, Bianco MV, Blanco FC, Nuñez J, Klepp LI, Vazquez CL, et al. 2013. Study of the in vivo role of Mce2R, the transcriptional regulator of mce2 operon in Mycobacterium tuberculosis. BMC Microbiol. 13: 200. DOI |
79 | Fukui Y, Hirai T, Uchida T, Yoneda M. 1965. Extracellular proteins of tubercle bacilli. IV. Alpha and beta antigens as major extracellular protein products and as cellular components of a strain (H37Rv) of Mycobacterium tuberculosis. Biken J. 8: 189-199. |
80 | Ganguly N, Siddiqui I, Sharma P. 2008. Role of M. tuberculosis RD-1 region encoded secretory proteins in protective response and virulence. Tuberculosis 88: 510-517. DOI |
81 | Esparza M, Palomares B, García T, Espinosa P, Zenteno E, Mancilla R. 2014. PstS-1, the 38-kDa Mycobacterium tuberculosis glycoprotein, is an adhesin, which binds the macrophage mannose receptor and promotes phagocytosis. Scand. J. Immunol. Epub ahead. |
82 | Gehring AJ, Rojas RE, Canaday DH, David L, Harding CV, Boom WH, Lakey DL. 2003. The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc γ R1 on human macrophages through Toll-like receptor 2. Infect Immun. 71: 4487-4497. DOI |
83 | Gevaert K, Vandekerckhove J. 2000. Protein identification methods in proteomics proteomics. Electrophoresis 21: 1145-1154. DOI |
84 | Ernst JD, Trevejo-Nuñez G, Banaiee N. 2007. Genomics and the evolution, pathogenesis, and diagnosis of tuberculosis. J. Clin. Invest. 117: 1738-1745. DOI |
85 | Florczyk MA, Mccue LA, Stack RF, Hauer CR, Mcdonough KA. 2001. Identification and characterization of mycobacterial proteins differentially expressed under standing and shaking culture conditions, including Rv2623 from a novel class of putative ATP-binding proteins. Infect. Immun. 69: 5777-5785. DOI |
86 | Espitia C, Laclette JP, Mondrago M, Amador A, Campuzano J, Martens A, et al. 1999. The PE-PGRS glycine-rich proteins of Mycobacterium tuberculosis: a new family of fibronectin-binding proteins? Microbiology 145: 3487-3495. DOI |
87 | Espitia C, Rodríguez E, Ramón-Luing L, Echeverría-Valencia G, Vallecillo AJ. 2012. Host – pathogen interactions in tuberculosis, pp. 43-76. In Cardona PJ (ed.). Understanding Tuberculosis. Analyzing the Origen of Mycobacterium Tuberculosis Pathogenicity. 1st Ed. InTech, Rijeka, Croatia. |
88 | Fay A, Glickman MS. 2014. An essential nonredundant role for mycobacterial DnaK in native protein folding. PLoS Genet. 10: e1004516. DOI |
89 | Daniel TM, Janicki BW. 1978. Mycobacterial antigens: a review of their isolation, chemistry, and immunological properties. Microbiol. Rev. 42: 84-113. |
90 | Flores-Villalva S, Suárez-Güemes F, Espitia C, Whelan AO, Vordermeier M, Gutiérrez-Pabello JA. 2012. Specificity of the tuberculin skin test is modified by use of a protein cocktail containing ESAT-6 and CFP-10 in cattle naturally infected with Mycobacterium bovis. Clin. Vaccine Immunol. 19: 797-803. DOI |
91 | Darwin KH, Lin G, Chen Z, Li H, Nathan CF. 2005. Characterization of a Mycobacterium tuberculosis proteasomal ATPase homologue. Mol. Microbiol. 55: 561-571. DOI |
92 | Drumm JE, Mi K, Bilder P, Sun M, Lim J, Bielefeldt-Ohmann H, et al. 2009. Mycobacterium tuberculosis universal stress protein Rv2623 regulates bacillary growth by ATP-Binding: requirement for establishing chronic persistent infection. PLoS Pathog. 5: e1000460. DOI |
93 | De Souza GA, Fortuin S, Aguilar D, Pando RH, McEvoy CRE, van Helden PD, et al. 2010. Using a label-free proteomics method to identify differentially abundant proteins in closely related hypo- and hypervirulent clinical Mycobacterium tuberculosis Beijing isolates. Mol. Cell. Proteomics 9: 2414-2423. DOI |
94 | De Souza GA, Leversen NA, Målen H, Wiker HG. 2011. Bacterial proteins with cleaved or uncleaved signal peptides of the general secretory pathway. J. Proteomics 75: 502-510. DOI |
95 | Deenadayalan A, Sundaramurthi JC, Raja A. 2010. Immunological and proteomic analysis of preparative isoelectric focusing separated culture filtrate antigens of Mycobacterium tuberculosis. Exp. Mol. Pathol. 88: 156-162. DOI |
96 | Muñoz-Elías EJ, McKinney JD. 2006. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat. Med. 11: 638-644. DOI |
97 | Cho YS, Dobos KM, Prenni J, Yang H, Hess A, Andersen P, et al. 2013. Deciphering the proteome of the in vivo diagnostic reagent "purified protein derivative" from Mycobacterium tuberculosis. Proteomics 12: 979-991. DOI |
98 | Ernst JD. 2012. The immunological life cycle of tuberculosis. Nat. Rev. Immunol. 12: 581-591. DOI |
99 | Borsuk S, Newcombe J, Mendum TA, Dellagostin OA, McFadden J. 2009. Identification of proteins from tuberculin purified protein derivative (PPD) by LC-MS/MS. Tuberculosis (Edinb.) 89: 423-430. DOI |
100 | Brewis IA, Brennan P. 2010. Proteomics technologies for the global identification and quantification of proteins. Adv. Protein Chem. Struct. Biol. 80: 1-44. DOI |
101 | Chao MC, Rubin EJ. 2010. Letting sleeping dos lie: does dormancy play a role in tuberculosis? Annu. Rev. Microbiol. 64: 293-311. DOI |
102 | Chen JM, Boy-Röttger S, Dhar N, Sweeney N, Buxton RS, Pojer F, et al. 2012. EspD is critical for the virulence-mediating ESX-1 secretion system in Mycobacterium tuberculosis. J. Bacteriol. 194: 884-893. DOI |
103 | Cho SH, Goodlett D, Franzblau S. 2006. ICAT-based comparative proteomic analysis of non-replicating persistent Mycobacterium tuberculosis. Tuberculosis (Edinb.) 86: 445-460. DOI |
104 | Chopra P, Singh A, Koul A, Ramachandran S, Drlica K, Tyagi AK, Singh Y. 2003. Cytotoxic activity of nucleoside diphosphate kinase secreted from Mycobacterium tuberculosis. Eur. J. Biochem. 270: 625-634. DOI |
105 | Comstock GW. 1975. Frost revisited: the modern epidemiology of tuberculosis. Am. J. Epidemiol. 101: 363-382. DOI |
106 | Daffé M, Etienne G. 1999. The capsule of Mycobacterium tuberculosis and its implications for pathogenicity. 79: 153-169. DOI |
107 | Ang K, Ibrahim P, Gam L. 2014. Analysis of differentially expressed proteins in late-stationary growth phase of Mycobacterium tuberculosis H37Rv. Biotechnol. Appl. Biochem. 61: 153-164. DOI |
108 | Abdallah AM, Gey van Pittius NC, Champion P a D, Cox J, Luirink J, Vandenbroucke-Grauls CMJE, et al. 2007. Type VII secretion--mycobacteria show the way. Nat. Rev. Microbiol. 5: 883-891. DOI |
109 | Albrethsen J, Agner J, Piersma SR, Højrup P, Pham T V, Weldingh K, et al. 2013. Proteomic profiling of Mycobacterium tuberculosis identifies nutrient-starvation-responsive toxinantitoxin systems. Mol. Cell. Proteomics 12: 1180-1191. DOI |
110 | Bergstedt W, Tingskov PN, Thierry-Carstensen B, Hoff ST, Aggerbeck H, Thomsen VO, et al. 2010. First-in-man open clinical trial of a combined rdESAT-6 and rCFP-10 tuberculosis specific skin test reagent. PLoS One 5: e11277. DOI |
111 | Bell C, Smith T, Sweredoski MJ, Hess S. 2012. Characterization of the Mycobacterium tuberculosis proteome by liquid chromatography mass spectrometry-based proteomics techniques: a comprehensive resource for tuberculosis research. J. Proteome Res. 11: 119-130. DOI |
112 | Berger BJ, Knodel MH. 2003. Characterisation of methionine adenosyltransferase from Mycobacterium smegmatis and M. tuberculosis. BMC Microbiol. 3: 1-13. DOI |
113 | Bhatt A, Fujiwara N, Bhatt K, Gurcha SS, Kremer L, Chen B, et al. 2007. Deletion of kasB in Mycobacterium tuberculosis causes loss of acid-fastness and subclinical latent tuberculosis in immunocompetent mice. Proc. Natl. Acad. Sci. USA 104: 5157-5162. DOI |
114 | Boon C, Li R, Qi R, Dick T. 2001. Proteins of Mycobacterium bovis BCG induced in the wayne dormancy model.J. Bacteriol. 183: 2672-2676. DOI |